Polyrizon initiates human study for NASARIX allergy blocker

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. AMD
4. INFY
5. RNG
6. UNP
7. DGX
8. ACI
9. URI
10. ARGX

Go back to Polyrizon initiates human study for NASARIX allergy blocker
(NASDAQ: PLRZ) Delayed: 14.50 -0.81 (5.29%)
Previous Close $15.31    52 Week High $ 
Open $14.91    52 Week Low $ 
Day High $15.58    P/E N/A 
Day Low $14.50    EPS $ 
Volume 1,600